LIC MF Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.52 %Nav, as on 12-08-2025

  • Previous Nav

  • Net Change on 12-08-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
LIC MF Healthcare Fund-Regular Plan-Growth -0.60 6.14 5.23 18.60 13.74 17.95
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
LIC MF Healthcare Fund-Regular Plan-Growth Feb 28, 2019 5.23 18.60 13.74 2.45 90.98
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 1.49 21.84 17.84 1.80 8,736.57
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 7.68 26.71 20.56 1.89 6,103.96
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 9.62 25.75 19.46 1.93 4,026.55
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 3.12 22.89 18.91 1.93 3,190.15
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 3.27 20.40 17.94 1.93 2,908.21

Fund Holdings as on 31-July-2025

  • Sun Pharmaceutical Industries Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Cipla Ltd.

  • Treps

  • Divi's Laboratories Ltd.

  • Fortis Healthcare Ltd.

  • Aurobindo Pharma Ltd.

  • Piramal Pharma Ltd.

  • Abbott India Ltd.

  • Neuland Laboratories Ltd.

  • Alkem Laboratories Ltd.

  • Gland Pharma Ltd.

  • IPCA Laboratories Ltd.

  • Artemis Medicare Services Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Navin Fluorine International Ltd.

  • Metropolis Healthcare Ltd.

  • Dr Agarwal's Health Care Ltd.

  • Mankind Pharma Ltd.

  • Concord Biotech Ltd.

  • Max Healthcare Institute Ltd.

  • Syngene International Ltd.

  • Global Health Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Vinati Organics Ltd.

  • Onesource Specialty Pharma Ltd.

  • Cohance Lifesciences Ltd.

  • Acutaas Chemicals Ltd.

  • Zydus Lifesciences Ltd.

  • Linde India Ltd.

  • Anthem Biosciences Ltd.

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Miscellaneous

  • Business Support

  • Industrial Gases & Fuels

View More

  • Cash

  • Equity

View More

About LIC MF Healthcare Fund

Scheme Analysis

LIC MF Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to LIC Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹90.98 crore. LIC MF Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of LIC MF Healthcare Fund ended up ₹0.15(0.52%)yesterday to ₹29.1784.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The LIC MF Healthcare Fund is managed by Karan Doshi .

Fund House Contact

4th Floor, Industrial Assurance Building, Opp. Churchgate Station, Mumbai - 400 020

022-66016000
service@licnomuramf.com
022-22880633